Healthcare expenditure on over-the-counter medicines in Sweden is forecasted to remain stable from 2024 to 2028, consistently accounting for 0.25% of GDP. This data suggests no year-on-year variation over the forecast period, implying a stagnant growth trend in this segment of healthcare spending.
As of 2023, historical data indicates that the expenditure on over-the-counter medicines stood steady, providing a reliable benchmark for the forecasted figures. The absence of any percentage change year-on-year over the last two years supports the observation of a flat trend.
Key future trends to watch for include:
- Potential policy changes impacting OTC medicine regulation and pricing.
- Market dynamics influenced by new entrants and product innovation.
- Consumer behavior shifts towards alternative medicine and wellness products.
- The impact of digital health solutions on OTC medicine consumption.
